Gradient Investments’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1
Closed -$48 1899
2023
Q3
$48 Hold
1
﹤0.01% 1748
2023
Q2
$68 Buy
+1
New +$64 ﹤0.01% 1703
2016
Q2
Sell
-17
Closed -$1K 772
2016
Q1
$1K Hold
17
﹤0.01% 686
2015
Q4
$1K Hold
17
﹤0.01% 638
2015
Q3
$1K Hold
17
﹤0.01% 554
2015
Q2
$1K Hold
17
﹤0.01% 582
2015
Q1
$1K Buy
+17
New +$436 ﹤0.01% 596
2014
Q4
Sell
-17
Closed 589
2014
Q3
$0 Hold
17
﹤0.01% 521
2014
Q2
$0 Hold
17
﹤0.01% 555
2014
Q1
$1K Hold
17
﹤0.01% 492
2013
Q4
$0 Hold
17
﹤0.01% 642
2013
Q3
$0 Hold
17
﹤0.01% 571
2013
Q2
$0 Buy
+17
New +$158 ﹤0.01% 488

Other funds holding PRTA

Gradient Investments's PRTA Position: Q4 2023 in Review

Gradient Investments sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 1 share — an estimated $48 sold.

Gradient Investments first reported a position in PRTA in Q2 2013 and held it in 13 quarters. The position peaked at $1K in Q1 2016. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • Gradient Investments reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
  • Gradient Investments sold 1 Prothena Corp share in Q4 2023, an estimated $48.
  • Gradient Investments first reported a position in Prothena Corp in Q2 2013 and held it in 13 quarters.
  • Gradient Investments's Prothena Corp position peaked at $1K in Q1 2016.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on Gradient Investments's 13F filing for Q4 2023, filed 18 Jan 2024.